Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection
Keyword(s):
Abstract This retrospective study reports the data of sofosbuvir-based anti-hepatitis C virus treatment in 24 candidates and 24 recipients of liver transplantation coinfected with human immunodeficiency virus. Sustained virologic response was cumulatively 85% (90% and 100% in those treated with optimal schedules pre- and posttransplant, respectively).
2007 ◽
Vol 52
(12)
◽
pp. 3423-3430
◽
2013 ◽
Vol 158
(9)
◽
pp. 1889-1894
◽
2009 ◽
Vol 15
(8)
◽
pp. 996
◽
1994 ◽
Vol 130
(5)
◽
pp. 664-665
◽
2003 ◽
Vol 187
(5)
◽
pp. 872-872
◽
2016 ◽
Vol 88
(11)
◽
pp. 1960-1966
◽